Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Investing Activities (2016 - 2025)

Collegium Pharmaceutical has reported Cash from Investing Activities over the past 10 years, most recently at -$20.1 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$20.1 million for Q4 2025, down 70.63% from a year ago — trailing twelve months through Dec 2025 was -$63.5 million (up 77.92% YoY), and the annual figure for FY2025 was -$63.5 million, up 77.92%.
  • Cash from Investing Activities for Q4 2025 was -$20.1 million at Collegium Pharmaceutical, up from -$30.9 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for COLL hit a ceiling of -$113000.0 in Q3 2022 and a floor of -$572.2 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was -$6.4 million (2023), compared with a mean of -$49.9 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 133586.21% in 2022 and later surged 99.97% in 2023.
  • Collegium Pharmaceutical's Cash from Investing Activities stood at -$515000.0 in 2021, then plummeted by 82.52% to -$940000.0 in 2022, then plummeted by 2569.89% to -$25.1 million in 2023, then soared by 53.13% to -$11.8 million in 2024, then plummeted by 70.63% to -$20.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$20.1 million (Q4 2025), -$30.9 million (Q3 2025), and -$2.9 million (Q2 2025) per Business Quant data.